Compare HLN & AMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLN | AMP |
|---|---|---|
| Founded | 2022 | 1894 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8B | 50.3B |
| IPO Year | 2021 | 2009 |
| Metric | HLN | AMP |
|---|---|---|
| Price | $10.05 | $491.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 14 |
| Target Price | $11.93 | ★ $566.00 |
| AVG Volume (30 Days) | ★ 16.4M | 494.3K |
| Earning Date | 07-30-2026 | 10-29-2026 |
| Dividend Yield | ★ 1.84% | 1.39% |
| EPS Growth | N/A | ★ 9.77 |
| EPS | N/A | ★ 21.64 |
| Revenue | N/A | ★ $18,911,000,000.00 |
| Revenue This Year | $3.30 | $5.78 |
| Revenue Next Year | $4.18 | $6.05 |
| P/E Ratio | $49.05 | ★ $22.49 |
| Revenue Growth | N/A | ★ 5.49 |
| 52 Week Low | $8.65 | $422.37 |
| 52 Week High | $11.28 | $572.56 |
| Indicator | HLN | AMP |
|---|---|---|
| Relative Strength Index (RSI) | 66.09 | 41.19 |
| Support Level | $9.63 | $486.20 |
| Resistance Level | $10.27 | $517.74 |
| Average True Range (ATR) | 0.14 | 9.82 |
| MACD | 0.13 | 1.10 |
| Stochastic Oscillator | 86.24 | 38.24 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating profit from advice and wealth management. With nearly $1.2 trillion in segment assets under management and advisory at year-end 2025, and with roughly 10,600 affiliated and employee advisors, Ameriprise is one of the larger US-based wealth managers. It also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $678 billion in assets under management at year-end 2025. The firm's third segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.69 trillion in assets under management and advisory across segments at year-end 2025.